Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Clinica Animedica

Research site

Romania Strada Caimetei nr.20, 021056 Bucharest, Romania

  • 2 trials recruiting
  • Schizophrenia · Autism spectrum disorder
  • Children and adolescents

About Specializations

Clinica Animedica in Bucharest, Romania specialises in clinical trials of conditions such as Schizophrenia, Autism spectrum disorder, and other specialisations. This site conducts important research.

Main research areas of the site

Nervous System Diseases

At Clinica Animedica, researchers are exploring new treatments for schizophrenia in adolescents, aiming to improve symptom control and safety.

  • Efficacy of KarXT in teenage schizophrenia
  • Safety profile of KarXT over long‑term use

The department’s focus on nervous system disorders supports innovative therapies for young patients.

Mental Disorders

The psychiatry unit is also evaluating interventions for irritability linked to autism spectrum disorder in children and teens.

  • Combination therapy KarXT+KarX‑EC for ASD‑related irritability
  • Comparative study of KarXT versus placebo in adolescent schizophrenia

Clinica Animedica’s commitment to mental health research drives these youth‑focused trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Strada Caimetei nr.20021056 BucharestRomania
Open in maps ↗
Recruiting now
2 trials
Conditions studied
2

More sites in BucharestRomania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Schizophrenia+1

Recruiting

Long‑Term Safety and Tolerability of KarXT in Adolescents with Schizophrenia and of KarXT + KarX‑EC in Children and Adolescents with Autism‑Related Irritability

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Schizophrenia

Recruiting

A study to evaluate the efficacy and safety of trospium chloride and xanomeline tartrate for the treatment of schizophrenia in adolescents aged 13 to 17 years

Investigational
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.